Bath & Body Works, Inc. (NYSE:BBWI – Get Free Report) was the recipient of some unusual options trading on Monday. Stock traders acquired 16,219 put options on the stock. This is an increase of 157% compared to the average daily volume of 6,317 put options.
Analyst Upgrades and Downgrades
Several research firms recently weighed in on BBWI. Morgan Stanley dropped their price objective on Bath & Body Works from $51.00 to $48.00 and set an “overweight” rating for the company in a research note on Thursday, November 21st. Cowen reiterated a “buy” rating on shares of Bath & Body Works in a report on Thursday, February 27th. Telsey Advisory Group reiterated an “outperform” rating and set a $43.00 target price on shares of Bath & Body Works in a report on Thursday, February 27th. Robert W. Baird increased their target price on Bath & Body Works from $45.00 to $47.00 and gave the company an “outperform” rating in a report on Friday, February 28th. Finally, JPMorgan Chase & Co. set a $47.00 target price on Bath & Body Works in a report on Thursday, February 27th. Five analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $45.06.
Get Our Latest Research Report on Bath & Body Works
Institutional Inflows and Outflows
Bath & Body Works Stock Performance
Bath & Body Works stock traded up $0.41 during midday trading on Monday, reaching $29.91. The stock had a trading volume of 1,430,828 shares, compared to its average volume of 4,068,111. Bath & Body Works has a twelve month low of $26.21 and a twelve month high of $52.99. The stock has a market capitalization of $6.48 billion, a PE ratio of 7.30, a price-to-earnings-growth ratio of 0.92 and a beta of 1.89. The stock’s 50-day simple moving average is $36.36 and its 200 day simple moving average is $34.00.
Bath & Body Works (NYSE:BBWI – Get Free Report) last issued its earnings results on Thursday, February 27th. The company reported $2.09 earnings per share for the quarter, beating analysts’ consensus estimates of $2.04 by $0.05. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The firm had revenue of $2.79 billion for the quarter, compared to analysts’ expectations of $2.78 billion. Equities analysts predict that Bath & Body Works will post 3.3 earnings per share for the current fiscal year.
Bath & Body Works declared that its board has approved a stock repurchase plan on Thursday, February 27th that authorizes the company to repurchase $500.00 million in outstanding shares. This repurchase authorization authorizes the company to repurchase up to 6.4% of its shares through open market purchases. Shares repurchase plans are usually a sign that the company’s board of directors believes its stock is undervalued.
Bath & Body Works Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Friday, March 7th. Shareholders of record on Friday, February 21st were given a $0.20 dividend. This represents a $0.80 annualized dividend and a yield of 2.67%. The ex-dividend date of this dividend was Friday, February 21st. Bath & Body Works’s dividend payout ratio (DPR) is presently 21.98%.
Bath & Body Works Company Profile
Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
Read More
- Five stocks we like better than Bath & Body Works
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Super Micro’s International Presence Makes It a Winning Stock
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Grocery Outlet Insider and Institutional Buyers Signal Bottom
- Investing in Commodities: What Are They? How to Invest in Them
- Consumers Are Cutting Back, But These 3 Stocks Will Stay Strong
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.